Centivax

About Centivax

Centivax is a biotechnology company focused on vaccine research and development, headquartered in South San Francisco, California. The company’s mission centers on accelerating the world’s transition to a post-pathogen era by developing broad-spectrum vaccines, notably a universal influenza vaccine that is in preclinical development for ferrets and pigs. Centivax has been recognized for its research in immunology and vaccinology, with a track record of funding and media exposure highlighting its pursuit of universal influenza prevention.